Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ainos, Inc. - warrants (NQ:AIMDW)

0.2550 +0.1449 (+131.61%)
Streaming Delayed Price Updated: 1:06 PM EDT, Aug 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ainos, Inc. - warrants

< Previous 1 2 3 4 Next >
Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting
Via ACCESS Newswire
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome
Via ACCESS Newswire
Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation
Via ACCESS Newswire
Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector
Via ACCESS Newswire
Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026
Via ACCESS Newswire
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
Via ACCESS Newswire
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
Via ACCESS Newswire
Ainos Reports Full Year 2024 Financial Results
Via ACCESS Newswire
Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships
Via ACCESS Newswire
Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape
Via ACCESS Newswire
Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization
Via ACCESS Newswire
Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites
Via ACCESS Newswire
Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation
Via ACCESS Newswire
Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here
Via ACCESS Newswire
Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
Via ACCESS Newswire
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25
Via ACCESS Newswire
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy
Via ACCESS Newswire
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
Via ACCESS Newswire
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
Via ACCESS Newswire
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
Via ACCESS Newswire
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors
Via ACCESS Newswire
Ainos Reports First Quarter 2025 Financial Results
Via ACCESS Newswire
Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing
Via ACCESS Newswire
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
Via ACCESS Newswire
Ainos and ugo Complete First Robotic Smell Integration in Japan
Via ACCESS Newswire
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
Via ACCESS Newswire
Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling
Via ACCESS Newswire
Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
Via ACCESS Newswire
Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More
Via ACCESS Newswire
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation
Via ACCESS Newswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.